| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53d83bb1ff8e49456fdc34ae01a71c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e6e31f113fe7e700eb55ebe3da92f05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0296dbbb070df78021d8a785b6568e3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_052a9bacfbfbce39f6287dd1e03d2aeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbee3ed7c2b4c240b18347ff8c0dd1f8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2003-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f53ebd4b77000992705b88bc686b5a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc09eeda888768be919e2a2dde31073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8249e2c5aba834883b690f17fa5e90a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d45d735cfcc13d2a7a1634f6608ae73e |
| publicationDate |
2003-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03099229-A2 |
| titleOfInvention |
Functional protein expression for rapid cell-free phenotyping |
| abstract |
Disclosed herein are methods for assaying the phenotype of a bioactive molecule in the presence and absence of compounds that are known inhibitors of the phenotypable activity of the bioactive molecule. Also disclosed are methods for discovering compounds that can inhibit the phenotypable activity of a bioactive molecule. The methods and assays of the present invention are useful in developing and monitoring a chemotherapy regimen for a patient, to detect or prevent the emergence of a drug resistant phenotype. |
| priorityDate |
2002-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |